Jove
Visualize
Contact Us

Related Concept Videos

Depression: Overview01:18

Depression: Overview

936
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
936
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

964
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
964
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.6K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.6K
Drug Therapy01:28

Drug Therapy

315
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
315
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

842
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
842
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

665
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
665

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Redefining the physician executive.

Physician executiveยท2009
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Feb 17, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.7K

Management of depression.

Russel Kuzel

    Postgraduate Medicine
    |December 12, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Depression is treatable but often missed in primary care. This article offers strategies for improved depression detection and management, addressing challenges posed by antidepressant side effects.

    More Related Videos

    Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
    08:15

    Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

    Published on: June 6, 2025

    648
    Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
    04:33

    Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

    Published on: April 26, 2024

    1.6K

    Related Experiment Videos

    Last Updated: Feb 17, 2026

    Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
    04:29

    Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

    Published on: January 7, 2019

    29.7K
    Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
    08:15

    Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

    Published on: June 6, 2025

    648
    Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
    04:33

    Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

    Published on: April 26, 2024

    1.6K

    Area of Science:

    • General Medicine
    • Psychiatry
    • Primary Care Practice

    Background:

    • Depression is a prevalent and treatable condition.
    • Underdiagnosis and management difficulties, often due to antidepressant adverse effects, are common in primary care.
    • Effective interventions are crucial for improving patient outcomes.

    Purpose of the Study:

    • To provide recommendations for enhancing the detection of depression in primary care settings.
    • To outline strategies for optimizing the treatment of depression, considering potential adverse effects of therapies.
    • To address the challenges associated with managing depression in a primary care context.

    Main Methods:

    • Review of current clinical guidelines and evidence for depression screening.
    • Analysis of common antidepressant adverse effects and management strategies.
    • Synthesis of practical recommendations for primary care physicians.

    Main Results:

    • Primary care settings are key for early depression detection.
    • Managing depression requires careful consideration of treatment options and side effect profiles.
    • Proactive management strategies can improve treatment adherence and efficacy.

    Conclusions:

    • Improved detection and management protocols are essential for addressing depression in primary care.
    • Addressing antidepressant-related adverse effects is critical for successful treatment.
    • Implementing evidence-based recommendations can enhance the care of patients with depression.